Fluvirin influenza virus vaccine

Influenza Virus Vaccine, Fluvirin vaccine, Types A and B (Surface Antigen) is a sterile parenteral for intramuscular use only. It is a purified sub-unit vaccine. Fluvirin vaccine is prepared from the extraembryonic fluid of embryonated chicken eggs inoculated with a specific type of influenza virus suspension containing neomycin and polymyxin.

 Fluvirin influenza virus vaccine multidose vial

  • 5-mL multidose vial
  • Packaged individually in a carton
  • NDC #66521-116-10
Storage and handling
  1. Immediately remove the temperature indicator prior to storing. Be sure to carefully read the instructions
  2. Remove the gel packs
  3. Remove the product from shipping box and store vaccine in a refrigerator
Store Fluvirin vaccine refrigerated between 2ºC and 8ºC (36ºF and 46ºF).
Do not freeze. Discard if the vaccine has been frozen. Store in the original package to protect from light. Do not use after the expiration date. Between uses, return the multidose vial to the recommended storage conditions.

 
Vaccines may run the risk of being damaged when exposed to freezing temperatures during shipment and storage.

Multidose vial, 5-mL. Contains thimerosal, a mercury derivative (25 mcg mercury
per 0.5-mL dose). Thimerosal is added as a preservative.

Fluvirin influenza virus vaccine prefilled syringe
 

  • 0.5-mL Luer-Lok® syringe (without needles)
  • Package of 10 prefilled syringes per carton
  • NDC #66521-116-02
Storage and handling

  1. Immediately remove the temperature indicator prior to storing. Be sure to carefully read the instructions
  2. Remove the gel packs
  3. Remove the product from shipping box and store vaccine in a refrigerator

Store Fluvirin vaccine refrigerated between 2ºC and 8ºC (36ºF and 46ºF).
Do not freeze. Discard if the vaccine has been frozen. Store in the original package to protect from light. Do not use after the expiration date. Between uses, return the multidose vial to the recommended storage conditions. 

Vaccines may run the risk of being damaged when exposed to freezing temperatures during shipment and storage.

Prefilled syringe, 0.5-mL. Thimerosal, a mercury derivative used during
manufacture, is removed by subsequent purification steps to a trace amount (≤1 mcg
mercury per 0.5-mL dose).

Important safety information
Serious allergic reactions, including anaphylactic shock, have been observed in people receiving FLUVIRIN Influenza Virus Vaccine. FLUVIRIN vaccine should not be administered to individuals with a history of systemic hypersensitivity reaction to eggs or egg proteins or other components of FLUVIRIN vaccine, including thimerosal, or to anyone who has had a life-threatening reaction to previous influenza vaccination.

Pre-filled syringes of 2010/2011 FLUVIRIN influenza vaccine are tipped with caps which may contain natural rubber latex in trace amounts. Do not administer pre-filled syringe doses of FLUVIRIN vaccine to any patients with a demonstrated history of hypersensitivity to latex. Multi-dose vial presentations of FLUVIRIN are latex-free.

In clinical trials, the most common adverse events in adults were headache, fatigue, injection site reactions (pain, mass, redness, and induration), and malaise. These adverse events were generally mild/moderate and transient. Vaccination with FLUVIRIN vaccine may not protect all individuals who are susceptible to influenza.

Immunocompromised persons, including individuals receiving immunosuppressive therapy, may have a reduced immune response to FLUVIRIN vaccine. If Guillain-Barré syndrome has occurred within 6 weeks of receipt of prior influenza vaccine, the decision to use FLUVIRIN vaccine should be based on careful consideration of the potential benefits and risks. All people, including those who are pregnant, nursing, and/or taking other medications, should consult their healthcare providers before receiving FLUVIRIN vaccine.
 

 
   
       
 
 
Order Fluvirin®
 

 
 

Other Vaccines